Cidara Therapeutics, Inc.

NasdaqCM:CDTX Stock Report

Market Cap: US$254.0m

Cidara Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CDTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 24SellUS$10,752Taylor SandisonIndividual924US$11.64
11 Sep 24SellUS$10,580Leslie TariIndividual909US$11.64
07 Jun 24BuyUS$105,680Jeffrey SteinIndividual8,000US$13.21
11 Mar 24SellUS$12,680Preetam ShahIndividual946.55US$13.40
11 Mar 24SellUS$13,713Shane WardIndividual1,023.65US$13.40
11 Mar 24SellUS$14,085Leslie TariIndividual1,051.45US$13.40
11 Mar 24SellUS$13,839Taylor SandisonIndividual1,033.1US$13.40

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CDTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders106,8210.977%
Private Companies239,0702.19%
Hedge Funds703,0656.43%
Institutions1,306,17711.9%
General Public3,642,59433.3%
VC/PE Firms4,941,18045.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 141.9%.

Top Shareholders

Top 25 shareholders own 66.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.99%
RA Capital Management, L.P.
1,092,796US$25.4m55.4%0.31%
9.2%
TCG Crossover Management, LLC
1,005,901US$23.4m0%2.07%
7%
VR Adviser, LLC
765,723US$17.8m0%0.9%
6.43%
Canaan Management, Inc.
703,080US$16.3m0%11.82%
6.43%
Bain Capital Life Sciences Investors, LLC
703,080US$16.3m0%1.71%
6.43%
BVF Partners L.P.
703,065US$16.3m105%0.51%
6.13%
Vivo Capital, LLC
670,600US$15.6m0%1.31%
3.37%
Monashee Investment Management, LLC
369,099US$8.6m0%0.93%
2.19%
Mundipharma International Limited
239,070US$5.6m0%no data
1.67%
Checkpoint Capital, LLC, Asset Management Arm
182,426US$4.2m25.5%2.13%
1.65%
The Vanguard Group, Inc.
180,535US$4.2m0%no data
0.9%
Medical Strategy GmbH, Asset Management Arm
98,132US$2.3m0%0.14%
0.89%
Renaissance Technologies LLC
97,817US$2.3m2.41%no data
0.73%
Alethea Capital Management, LLC
79,908US$1.9m0%1.43%
0.67%
Jeffrey Stein
72,783US$1.7m0%no data
0.52%
5AM Venture Management, LLC
56,725US$1.3m0%0.29%
0.48%
Geode Capital Management, LLC
52,898US$1.2m22.7%no data
0.45%
BlackRock, Inc.
48,920US$1.1m0.84%no data
0.39%
Adage Capital Management, L.P.
42,755US$992.8k0%no data
0.29%
Northern Trust Global Investments
31,787US$738.1k0%no data
0.18%
Schonfeld Strategic Advisors LLC
19,500US$452.8k0.52%no data
0.13%
Millennium Management LLC
13,919US$323.2k0%no data
0.12%
State Street Global Advisors, Inc.
13,576US$315.2k0%no data
0.12%
Taylor Sandison
12,797US$297.2k16.1%no data
0.077%
Leslie Tari
8,424US$195.6k26.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:41
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cidara Therapeutics, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Timothy ChiangBTIG
Chiara RussoCantor Fitzgerald & Co.
Louise ChenCantor Fitzgerald & Co.